Navigation Links
Questcor Reports Fourth Quarter and Full Year 2012 Results
Date:2/26/2013

year growth, MS prescriptions softened by approximately 8% from the third quarter, after almost five years of sequential quarterly growth, and nephrotic syndrome became the largest contributor to net sales. At the same time, based on early, encouraging results from our pilot rheumatology commercial effort, we have just completed our rheumatology sales force expansion from 12 to 55 representatives." 

"We continue to invest in the future of both Acthar and our overall business capabilities," continued Mr. Bailey. "In addition to the rapid expansion of our R&D investment, we have also substantially expanded our sales force, our reimbursement and compliance teams, and our manufacturing capabilities. The recent acquisition of BioVectra, which gives us much greater control of our supply chain, deepens our manufacturing capabilities and scientific expertise, while also expanding and diversifying our business. The appointment of Michael Aldridge to lead our strategic development function was another important step as we look to broaden our capabilities and further diversify our business, while maintaining our focus on the potential of Acthar to help many more patients than it does today. We continue to balance our investments in the business with a disciplined program of returning capital to shareholders, as demonstrated by additional share repurchases and the institution of a regular quarterly dividend."

Full Year Financial ResultsNet sales for the full year of 2012 were $509.3 million, compared to $218.2 million in the full year of 2011. Cash flow from operations for the full year of 2012 was $219.0 million, compared to $85.6 million for the full year of 2011. GAAP earnings per share for the full year of 2012 were $3.14 per diluted common share, compared with $1.21 per diluted common share for the comparable period of 2011. Non-GAAP earnings per share for the full year ended December 31, 2012 were $3.33 per diluted common share, excluding non-cash
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
2. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
3. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
4. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
5. Questcor to Conduct Conference Call to Discuss Reimbursement Process
6. Questcor Comments on Insurance Policy Bulletin
7. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
8. Questcor Pharmaceuticals to Present at Investor Conferences in September
9. Questcor Reports Second Quarter Financial Results
10. Questcor to Report Second Quarter Results on July 24, 2012
11. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Men with benign prostatic hyperplasia (BPH), ... but not cancerous, have a new, breakthrough treatment ... complications than other minimally invasive treatments, such as ... according to research presented at the Society ... Meeting . Using an interventional radiology treatment known ...
(Date:3/3/2015)... -- Although lung cancer is the third most prevalent ... drugs in the market for its treatment. Further, popular ... patent expiry in 2015 and 2017 respectively. As such, ... drug manufacturers are vying to tap into. Approximately 130 ... (SCLC) and non-small cell lung cancer (NSCLC) are in ...
(Date:3/3/2015)... Chrono Therapeutics , a pioneer in ... Rock Health , the leading seed fund in digital ... transdermal drug delivery system and real-time behavioral support program ... than 500,000 Americans each year, and is responsible for ... United States . Of the 45 million smokers ...
Breaking Medicine Technology:Interventional radiology offers new treatment for enlarged prostates 2Interventional radiology offers new treatment for enlarged prostates 3Interventional radiology offers new treatment for enlarged prostates 4Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 2Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 3
... Reportlinker.com announces that a new market research ... Top Medical Devices and Imaging ... This research service discusses ... have excellent growth potential in the next ...
... , Pharma IQ has just published ... recently among 3,000,pharmaceutical distribution specialist with over 83 ... their respective,companies. The results showed that ... current level of service they received from,external partners ...
Cached Medicine Technology:Reportlinker Adds Top Medical Devices and Imaging Technologies 2011 2Pharma IQ's Pharma Distribution Survey report 2Pharma IQ's Pharma Distribution Survey report 3
(Date:3/3/2015)... Dr. Stephen Edgerton, a Cosmetic ... achieved Accredited Member Status in the American Academy ... accomplishment after completing a rigorous credentialing process including ... submission of clinical cases for examination. , ... in Connecticut, Charlotte, North Carolina, Caracas, Venezuela and ...
(Date:3/3/2015)... California (PRWEB) March 03, 2015 ... effect entitled inMotion3D Environment from Pixel Film Studios. , ... 2D HDRI image into 360° viewing area inside Motion ... “inMotion3D Environment blurs the line between professional and amateur ... 5 users can turn their 2D HDRI images into ...
(Date:3/3/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... that it will participate as an exhibitor at the ... 2015 in St. Louis, MO. , CareerMD Career Fairs ... and fellows in a comfortable, relaxed setting. , Representatives ... available to speak with attendees about its full range ...
(Date:3/3/2015)... Motion Graphics artist at ... new plugin FCPX3D Confetti designed exclusively for Final Cut ... using confetti particles inside FCPX,” said Christina Austin, CEO ... transition, users will have fun as they choose, drag, ... clip to the next with 3D tumbling or exploding ...
(Date:3/2/2015)... March 02, 2015 Formetco today announced ... design. The FTX uses state-of-the-art technology to deliver ... reliability, and owner satisfaction. An item of particular ... exclusive Formetco 10 year LED Brightness Warranty. , Why ... be a superior billboard among any other billboard product ...
Breaking Medicine News(10 mins):Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:A New Plugin Entitled inMotion3D Environment Was Released Today from Pixel Film Studios Exclusively for Motion 5 2Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2Health News:Formetco Launches Innovative LED Billboard System 2
... Nevique(TM), a newly,founded skin care company based ... Omega 3 skin care technology at the upcoming,ECRM/EPPS ... August 5-8, 2008. The,Nevique(TM) skin care line initially ... 1) Ultra Moisturizer, 2) Daily Conditioner, 3) Medicated,Mint, ...
... Delegation of the Commission will dialogue with leaders at,the ... response,to the HIV/AIDS pandemic, NEW YORK, July 30 ... affected community, it is estimated that more,than 200,000 individuals ... has reached a crisis level. Representing only 15.3% of,the ...
... manage consumers. , ... Orlando, FL (Vocus) July 31, ... Applications vendor in its "Hype Cycle for Healthcare Payers, 2008" report. ... to attract, retain and manage individual and small group ...
... MILLS, Md., July 31 Medifast, Inc.,(NYSE: ... published in ,The Journal,of Eating and Weight Disorders, ... double the weight loss when they combine,their drug ... Replacement,Supplements., The 52-week study, conducted by researchers ...
... http://www.publicintegrity.org/investigations/pesticides , Center Unveils New Report Based ... According to a new,Center for Public Integrity ... pyrethrins and,pyrethroids were responsible for more than 26 ... pesticides in the United States in 2007,up from ...
... in Kansas City Area, MERRIMACK, N.H., July ... shaping, Eleme Medical Inc. announced today that Gary ... plastic surgeon to offer the,SmoothShapes(R) system for longer-lasting ... Summit and Northland Kansas City. Rajeunir,is hosting a ...
Cached Medicine News:Health News:Nevique Skin Care Company Introducing the Revolutionary New Omega 3 Skin Care Technology 2Health News:The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City 2Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 2Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 3Health News:Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone 2Health News:'Safe' Pesticides Now First in Poisonings 2Health News:'Safe' Pesticides Now First in Poisonings 3Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 3
... Our most popular onsite test! QuickScreen multi-panel ... urine sample, and your choice of any ... multi-panels offer total flexibility for your drug ... the specimen and the built-in timer tells ...
... The SureStep™ Drug Screen Tests are available ... for MDMA (Ecstasy). Designed using Microgenics Antibody ... the only point of care immunoassay targeted ... for both MDA and MDEA but no ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... drugs of abuse tests are highly accurate in ... recommended cut-off as confirmed by GC/MS testing. This ... specific alternative method (such as GC/MS) must be ... Professional judgment should be applied to any drug ...
Medicine Products: